Erdoğan ÇETİNKAYA, Zehra YAŞAR

Bron şiyal termoplasti; astımda yeni tedavi seçeneği

Bron şiyal termoplasti, maksimal medikal tedavi ile kontrol altına alınamayan orta ve a ğır astımlı hastaların tedavisinde hava yollarınaradyofrekans enerjisi kullan ılarak kontrollü şekilde termal enerji uygulayan ve hava yolu düz kas kütlesinin azaltılmas ın ı hedefleyennonfarmakolojik tedavi seçene ğidir. İşlem bilinçli sedasyon altında ayaktan, bir saatten daha kısa süren üçer hafta ara ile üç bronkos-kopi seansı şeklinde gerçekle ştirilir. Bron şiyal termoplasti ile, orta ve a ğır astımlı hastalarda ya şam kalitesinde düzelme, şiddetli alev-lenmelerde, acil servis ba şvurularında ve iş/okul günü kay ıplarında anlamlı azalmalar tespit edilmiştir. Hasta konforu ve güvenliği içindikkatli hasta yönetimi önemlidir. Bu derlemede, bron şiyal termoplasti hakkında yapılm ış klinik çalışmaların, etkinliğine dair kan ıtla-rın, mevcut protokollerin ve hasta yönetiminin güncel bilgiler ışığında gözden geçirilmesi amaçlanm ıştır.

Bronchial thermoplasty; a new treatment modality in asthma

Bronchial thermoplasty is a non-drug treatment modality for moderate-to-severe asthma that involves the delivery of radio frequencyenergy to the airway wall in a precisely controlled manner to reduce excessive airway smooth muscle. Bronchial thermoplasty isperformed under conscious sedation and completed in three bronchoscopy sessions, each lasting less than one hour, and eachspaced apart by about three weeks. Bronchial thermoplasty has been demonstrated to reduce severe exacerbations, emergencyrooms visits for respiratory symptoms, and time lost from work, school and other daily activities and improve asthma control andquality of life in patients with moderate-to-severe asthma. Adequate patient management is important for patient comfort and safety.In this review, we aim to discuss clinical studies , the evidence for the efficacy of bronchial thermoplasty, the importance of carefulpatient selection, patient preparation, patient management, procedure

PDF

___

1. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343-73. PubMed PMID: 24337046. Epub 2013/12/18. eng.
2. Holgate ST, Chuchalin AG, Hebert J, Lotvall J, Persson GB, Chung KF, et al. Efficacy and safety of a recombinant anti- immunoglobulin E antibody (omalizumab) in severe aller- gic asthma. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2004;34:632-8. PubMed PMID: 15080818. Epub 2004/04/15. eng.
3. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for pred- nisone-dependent asthma with sputum eosinophilia. New England J Med 2009;360:985-93. PubMed PMID: 19264687. Epub 2009/03/07. eng.
4. Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, Dahlen SE, et al. A randomized, double-blind, placebo- controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 2009;179:549-58. PubMed PMID: 19136369. Epub 2009/01/13. eng.
5. Thomson NC, Bicknell S, Chaudhuri R. Bronchial thermo- plasty for severe asthma. Curr Opin Allergy Clin Immunol 2012;12:241-8. PubMed PMID: 22475996. Epub 2012/04/06. eng.
6. James AL, Elliot JG, Jones RL, Carroll ML, Mauad T, Bai TR, et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med 2012;185(10):1058- 64. PubMed PMID: 22403800. Epub 2012/03/10. eng.
7. Gounni AS, Wellemans V, Yang J, Bellesort F, Kassiri K, Gangloff S, et al. Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth mus- cle cell function. J Immunol (Baltimore, Md : 1950) 2005;175(4):2613-21. PubMed PMID: 16081836. Epub 2005/08/06. eng.
8. Hakonarson H, Carter C, Kim C, Grunstein MM. Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle. J Allergy Clin Immunol 1999;104(3 Pt 1):575-84. PubMed PMID: 10482830. Epub 1999/09/14. eng.
9. Howarth PH, Knox AJ, Amrani Y, Tliba O, Panettieri RA, Jr., Johnson M. Synthetic responses in airway smooth muscle. J Allergy Clin Immunol 2004;114(2 Suppl):S32-50. PubMed PMID: 15309017. Epub 2004/08/17. eng.
10. Johnson SR, Knox AJ. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacological Sciences 1997;18:288-92. PubMed PMID: 9277132. Epub 1997/08/01. eng.
11. Sukkar MB, Stanley AJ, Blake AE, Hodgkin PD, Johnson PR, Armour CL, et al. 'Proliferative' and 'synthetic' airway smooth muscle cells are overlapping populations. Immunol Cell Biology 2004;82:471-8. PubMed PMID: 15479432. Epub 2004/10/14. eng.
12. Janssen LJ. Asthma therapy: how far have we come, why did we fail and where should we go next? Eur Respir J 2009;33:11-20. PubMed PMID: 19118224. Epub 2009/01/02. eng.
13. Ambrogi MC, Fanucchi O, Lencioni R, Cioni R, Mussi A. Pulmonary radiofrequency ablation in a single lung patient. Thorax 2006;61:828-9. PubMed PMID: 16936239. Pubmed Central PMCID: Pmc2117088. Epub 2006/08/29. eng.
14. Benussi S, Cini R, Gaynor SL, Alfieri O, Calafiore AM. Bipolar radiofrequency maze procedure through a trans- septal approach. Annals Thoracic Surgery 2010;90:1025- 7. PubMed PMID: 20732547. Epub 2010/08/25. eng.
15. Danek CJ, Lombard CM, Dungworth DL, Cox PG, Miller JD, Biggs MJ, et al. Reduction in airway hyperresponsive- ness to methacholine by the application of RF energy in dogs. J Applied Physiology (Bethesda, Md : 1985). 2004;97:1946-53. PubMed PMID: 15258133. Epub 2004/07/20. eng.
16. Dyrda P, Tazzeo T, DoHarris L, Nilius B, Roman HN, Lauzon AM, et al. Acute response of airway muscle to extreme temperature includes disruption of actin-myosin interaction. Am Respiratory Cell and Molecular Biology 2011;44:213-21. PubMed PMID: 20395634. Epub 2010/04/17. eng.
17. Jesudason EC. Airway smooth muscle: an architect of the lung? Thorax 2009;64:541-5. PubMed PMID: 19478122. Epub 2009/05/30 eng.
18. Miller JD, Cox G, Vincic L, Lombard CM, Loomas BE, Danek CJ. A prospective feasibility study of bronchial ther- moplasty in the human airway. Chest 2005;127:1999- 2006. PubMed PMID: 15947312. Epub 2005/06/11. eng.
19. Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma. American J Respir Crit Care Med 2006;173:965-9. PubMed PMID: 16456145. Epub 2006/02/04. eng.
20. Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, et al. Effectiveness and safety of bron- chial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181:116-24. PubMed PMID: 19815809. Pubmed Central PMCID: Pmc3269231. Epub 2009/10/10. eng.
21. Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, et al. Asthma control during the year after bronchial thermoplasty. New England J Med 2007;356:1327-37. PubMed PMID: 17392302. Epub 2007/03/30. eng.
22. Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, et al. Safety and efficacy of bronchial thermo- plasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176:1185-91. PubMed PMID: 17901415. Epub 2007/09/29. eng.
23. Duhamel DR, Hales JB. Bronchial thermoplasty: a novel therapeutic approach to severe asthma. Journal of visual- ized experiments: JoVE 2010 (45). PubMed PMID: 21189463. Pubmed Central PMCID: PMC3159594. Epub 2010/12/30. eng.
24. Mayse ML, Laviolette M, Rubin AS, Lampron N, Simoff M, Duhamel D, et al. Clinical pearls for bronchial thermo- plasty. J Bronchol 2007;14:115-23.
25. Boston Scientific. Alair Bronchial Thermoplasty System. www.btforasthma.com Date last accessed: November 26, 2013.